secwatch.observer — SEC 8-K summary
======================================

Issuer:     Natera, Inc. (NTRA)
CIK:        0001604821
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001104659-22-056451
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Natera Q1 revenue $194.1M (+27.5% YoY), raises 2022 guidance to $790-810M
-------------------------------------------------------------------------

- Product revenue $190M, up 57.8% YoY; processed 489,300 tests, up 40.5%.
- Net loss $138.6M or ($1.45) per share vs. ($0.74) a year ago.
- Raised 2022 revenue guidance from $770-790M to $790-810M.
- Board and executives elect to take 100% equity compensation for remainder of 2022.
- Signatera ADLT reimbursement increased to $3,920 per test effective April 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604821/000110465922056451/0001104659-22-056451-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604821/000110465922056451/tm2214592d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-056451

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer